Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02BG06	EXEMESTANE	G	Exemestane - 25mg	25mg	Tablet, film coated	1,222,897 L.L
L02BG06	EXEMESTANE ARROW	G	Exemestane - 25mg	25mg	Tablet, film coated	3,386,483 L.L
L02BG06	EXEMESTANE BGR	G	Exemestane - 25mg	25mg	Tablet, coated	4,479,027 L.L
L02BG06	EXEMESTANE GENEPHARM	G	Exemestane - 25mg	25mg	Tablet, film coated	1,286,662 L.L
L02BG06	EXEMESTANE PHARMINICIO	G	Exemestane - 25mg	25mg	Tablet, film coated	1,158,392 L.L
C10AX09	EZETROL	B	Ezetimibe - 10mg	10mg	Tablet	3,680,849 L.L
C10AX09	EZETIMIBE BIOGARAN	G	Ezetimibe - 10mg	10mg	Tablet	1,894,818 L.L
C10AX09	EZETRALEX	G	Ezetimibe - 10mg	10mg	Tablet	972,686 L.L
R06AX26	EXOFEN	G	Fexofenadine HCl - 120mg	120mg	Tablet, film coated	287,582 L.L
R06AX26	EXOFEN	G	Fexofenadine HCl - 180mg	180mg	Tablet, film coated	287,582 L.L
L01BC02	EFUDIX	B	Fluorouracil - 5%	5%	Cream	671,921 L.L
S01BC04	EDOLFENE	B	Flurbiprofen sodium - 0.03%	0.03%	Drops solution	388,370 L.L
B03AD	EURO-FER CF	G	Folic acid - 0.5mg, Vitamin C - 200mg, Ferrous fumarate - 300mg		Capsule	706,861 L.L
V03AF03	EUROFOLIC	G	Folic acid as Calcium Folinate Hydrate - 100mg/10ml	10mg/ml	Injectable solution	L.L
V03AF03	EUROFOLIC	G	Folic acid as Calcium Folinate Hydrate - 100mg/10ml	10mg/ml	Injectable solution	5,872,592 L.L
V03AF03	EUROFOLIC	G	Folic acid as Calcium Folinate Hydrate - 50mg/5ml	10mg/ml	Injectable solution	5,305,490 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	37,250,732 L.L
J07BC01	ENGERIX-B 20	B	Hepatitis B, purified antigen - 20mcg/ml	20mcg/ml	Injectable suspension	1,652,926 L.L
J07BC01	ENGERIX-B 10	B	Hepatitis B, surface antigen - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	1,042,822 L.L
C03AA03	ESIDREX	B	Hydrochlorothiazide - 25mg	25mg	Tablet	380,115 L.L
D08AX01	EAU OXYGENEE 10/120	G	Hydrogen peroxide - 10V	10V	Solution	119,026 L.L
B03AB	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 156.25mg/5ml		Syrup	279,519 L.L
B03AB05	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 50mg/ml	50mg/ml	Drops	459,594 L.L
L04AX04	ERVALI	G	Lenalidomide - 10mg	10mg	Capsule, hard	71,493,520 L.L
L04AX04	ERVALI	G	Lenalidomide - 15mg	15mg	Capsule, hard	74,977,720 L.L
L04AX04	ERVALI	G	Lenalidomide - 25mg	25mg	Capsule, hard	81,147,769 L.L
L04AX04	ERVALI	G	Lenalidomide - 5mg	5mg	Capsule, hard	37,370,561 L.L
J01MA12	EVOXIL HELLAS	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
G03AD01	EZ-ONE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet	722,987 L.L
H03AA01	ELTROXIN	B	Levothyroxine sodium - 100mcg	100mcg	Tablet, scored	579,196 L.L